478 related articles for article (PubMed ID: 1629961)
41. Analysis of a human immunodeficiency virus type 1 gag mutant with an engineered 110-amino-acid insertion in the matrix protein domain.
Wang CT; Yang AH; Chiang CC
J Med Virol; 2000 Aug; 61(4):423-32. PubMed ID: 10897059
[TBL] [Abstract][Full Text] [Related]
42. Cell-dependent requirement of human immunodeficiency virus type 1 gp41 cytoplasmic tail for Env incorporation into virions.
Akari H; Fukumori T; Adachi A
J Virol; 2000 May; 74(10):4891-3. PubMed ID: 10775630
[TBL] [Abstract][Full Text] [Related]
43. Mutations at the C-terminus of the simian immunodeficiency virus envelope glycoprotein affect gp120-gp41 stability on virions.
Affranchino JL; González SA
Virology; 2006 Mar; 347(1):217-25. PubMed ID: 16380144
[TBL] [Abstract][Full Text] [Related]
44. The p2 domain of human immunodeficiency virus type 1 Gag regulates sequential proteolytic processing and is required to produce fully infectious virions.
Pettit SC; Moody MD; Wehbie RS; Kaplan AH; Nantermet PV; Klein CA; Swanstrom R
J Virol; 1994 Dec; 68(12):8017-27. PubMed ID: 7966591
[TBL] [Abstract][Full Text] [Related]
45. Incorporation of Vpr into human immunodeficiency virus type 1: role of conserved regions within the P6 domain of Pr55gag.
Checroune F; Yao XJ; Göttlinger HG; Bergeron D; Cohen EA
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Sep; 10(1):1-7. PubMed ID: 7648278
[TBL] [Abstract][Full Text] [Related]
46. Mutation of the dominant endocytosis motif in human immunodeficiency virus type 1 gp41 can complement matrix mutations without increasing Env incorporation.
West JT; Weldon SK; Wyss S; Lin X; Yu Q; Thali M; Hunter E
J Virol; 2002 Apr; 76(7):3338-49. PubMed ID: 11884559
[TBL] [Abstract][Full Text] [Related]
47. Chimeric HIV-1 containing SIV matrix exhibit enhanced assembly in murine cells and replicate in a cell-type-dependent manner in human T cells.
Chen P; Hübner W; Riviere K; Liu YX; Chen BK
Virology; 2006 May; 349(1):1-12. PubMed ID: 16563454
[TBL] [Abstract][Full Text] [Related]
48. Positive and negative modulation of virus infectivity and envelope glycoprotein incorporation into virions by amino acid substitutions at the N terminus of the simian immunodeficiency virus matrix protein.
Manrique JM; Celma CC; Hunter E; Affranchino JL; González SA
J Virol; 2003 Oct; 77(20):10881-8. PubMed ID: 14512538
[TBL] [Abstract][Full Text] [Related]
49. Insertion of a classical nuclear import signal into the matrix domain of the Rous sarcoma virus Gag protein interferes with virus replication.
Garbitt RA; Bone KR; Parent LJ
J Virol; 2004 Dec; 78(24):13534-42. PubMed ID: 15564464
[TBL] [Abstract][Full Text] [Related]
50. Impact of natural polymorphism within the gp41 cytoplasmic tail of human immunodeficiency virus type 1 on the intracellular distribution of envelope glycoproteins and viral assembly.
Lambelé M; Labrosse B; Roch E; Moreau A; Verrier B; Barin F; Roingeard P; Mammano F; Brand D
J Virol; 2007 Jan; 81(1):125-40. PubMed ID: 17050592
[TBL] [Abstract][Full Text] [Related]
51. Regulation of human immunodeficiency virus type 1 Env-mediated membrane fusion by viral protease activity.
Murakami T; Ablan S; Freed EO; Tanaka Y
J Virol; 2004 Jan; 78(2):1026-31. PubMed ID: 14694135
[TBL] [Abstract][Full Text] [Related]
52. Efficient particle formation can occur if the matrix domain of human immunodeficiency virus type 1 Gag is substituted by a myristylation signal.
Lee PP; Linial ML
J Virol; 1994 Oct; 68(10):6644-54. PubMed ID: 7521919
[TBL] [Abstract][Full Text] [Related]
53. Human immunodeficiency virus type 1 envelope protein endocytosis mediated by a highly conserved intrinsic internalization signal in the cytoplasmic domain of gp41 is suppressed in the presence of the Pr55gag precursor protein.
Egan MA; Carruth LM; Rowell JF; Yu X; Siliciano RF
J Virol; 1996 Oct; 70(10):6547-56. PubMed ID: 8794289
[TBL] [Abstract][Full Text] [Related]
54. Site-directed mutagenesis of the P2 region of the Rous sarcoma virus gag gene: effects on Gag polyprotein processing.
Bowles N; Bonnet D; Mulhauser F; Spahr PF
Virology; 1994 Aug; 203(1):20-8. PubMed ID: 8030280
[TBL] [Abstract][Full Text] [Related]
55. Dominant Negative MA-CA Fusion Protein Is Incorporated into HIV-1 Cores and Inhibits Nuclear Entry of Viral Preintegration Complexes.
Anderson-Daniels J; Singh PK; Sowd GA; Li W; Engelman AN; Aiken C
J Virol; 2019 Nov; 93(21):. PubMed ID: 31413124
[TBL] [Abstract][Full Text] [Related]
56. Rational site-directed mutations of the LLP-1 and LLP-2 lentivirus lytic peptide domains in the intracytoplasmic tail of human immunodeficiency virus type 1 gp41 indicate common functions in cell-cell fusion but distinct roles in virion envelope incorporation.
Kalia V; Sarkar S; Gupta P; Montelaro RC
J Virol; 2003 Mar; 77(6):3634-46. PubMed ID: 12610139
[TBL] [Abstract][Full Text] [Related]
57. Substitution of leucine 8 in the simian immunodeficiency virus matrix protein impairs particle formation without affecting N-myristylation of the Gag precursor.
González SA; Affranchino JL
Virology; 1998 Jan; 240(1):27-35. PubMed ID: 9448686
[TBL] [Abstract][Full Text] [Related]
58. Characterization of human immunodeficiency virus type 1 matrix revertants: effects on virus assembly, Gag processing, and Env incorporation into virions.
Ono A; Huang M; Freed EO
J Virol; 1997 Jun; 71(6):4409-18. PubMed ID: 9151831
[TBL] [Abstract][Full Text] [Related]
59. Reversion of a human immunodeficiency virus type 1 matrix mutation affecting Gag membrane binding, endogenous reverse transcriptase activity, and virus infectivity.
Kiernan RE; Ono A; Freed EO
J Virol; 1999 Jun; 73(6):4728-37. PubMed ID: 10233933
[TBL] [Abstract][Full Text] [Related]
60. Redundant roles for nucleocapsid and matrix RNA-binding sequences in human immunodeficiency virus type 1 assembly.
Ott DE; Coren LV; Gagliardi TD
J Virol; 2005 Nov; 79(22):13839-47. PubMed ID: 16254319
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
